CMC Biologics Information

CMC Biologics (CMC), a wholly-owned subsidiary of Asahi Glass Company (AGC), is one of the industry leading CMOs in reliability, technical excellence, and quality — Right and On Time. With three facilities in the USA and Europe, the Company provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical, and commercial production. The Company’s wide range of integrated services includes cell line development, bioprocess development, formulation development, and comprehensive analytical testing. Through the Company’s PROVEO™ Alliance, they provide clients a fully realized and configurable antibody drug conjugate (ADC) solution—from MAb process development and manufacture, to payload manufacture and conjugation, and on through fill, finish, labeling and packaging. Clients can also benefit from CMC Biologics’ proprietary CHEF1® expression system for mammalian production. CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes. Visit www.cmcbio.com to learn why CMC Biologics is a World Leader in process development and contract manufacturing.